RYZOLT
TRAMADOL HYDROCHLORIDE
Approval overview RYZOLT is listed in Drugs@FDA under application 021745 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient TRAMADOL HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PURDUE PHARMA Submission history Latest submission status date: 2008-12-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview RYZOLT is listed in Drugs@FDA under application 021745 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TRAMADOL HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PURDUE PHARMA Submission history Latest submission status date: 2008-12-30 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.